{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:54:03Z","timestamp":1793372043836,"version":"4.5.0"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>To evaluate the outcome of 577 nm yellow solid krypton laser as an independent treatment modality for Retinopathy of Prematurity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>Prospective, non-comparative, non-randomized, interventional.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A prospective pilot study was conducted on 30 treatment eyes with retinopathy of prematurity (ROP) who underwent treatment with a 577 nm yellow solid state krypton laser. 3nethraNEO pediatric retinal imaging system was used to screen these infants born between March to August 2022. Pre procedure data such as gestational age (weeks), birth weight (g), and exposure to risk factors were recorded. Power (mW), exposure duration (msec), and number of laser spots administered were noted. Pain was assessed using the Neonatal Pain\/Agitation and Sedation Scale (N-PASS). Post procedure data such as regression, persistence or reactivation of disease, and adverse effects were looked for. All eyes were followed up for a period of 3 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Statistical Analysis Used:<\/jats:title>\n                    <jats:p>Chi-square test, Fisher\u2019s exact test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>Out of 30 eyes, 09 (30%) had type I and 21 (70%) had non-type I ROP. In type I disease, the mean power used was 88+\/-10 mW with exposure duration of 130+\/-27 msec and an average number of 890+\/-260 burns were administered. In non-type I disease, the mean power used was 87+\/-10 mW with an exposure duration of 150 ms and an average number of 900+\/-290 burns were administered. The mean pain score calculated was 5 in type I and 6 in non-type I ROP. All eyes showed regression of disease after treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>577 nm yellow solid krypton laser was safe and effective in treating retinopathy of prematurity disease.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_2490_23","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T01:00:22Z","timestamp":1707181222000},"page":"856-859","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Safety and therapeutic efficacy of 577 nm yellow solid krypton laser for retinopathy of prematurity; A prospective pilot study"],"prefix":"10.4103","volume":"72","author":[{"given":"Aneesha","family":"Vyas","sequence":"first","affiliation":[{"name":"Vitreo-Retina Department, K B H Bachooali Charitable Ophthalmic and ENT Hospital, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarvesh","family":"Tiwari","sequence":"additional","affiliation":[{"name":"Vitreo-Retina Department, K B H Bachooali Charitable Ophthalmic and ENT Hospital, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Subramanyam","sequence":"additional","affiliation":[{"name":"Vitreo-Retina Department, K B H Bachooali Charitable Ophthalmic and ENT Hospital, Mumbai, Maharashtra, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,2,5]]},"reference":[{"issue":"Suppl 1","key":"R1-20260504","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1742-4755-10-S1-S5","article-title":"Born too soon: Care for the preterm baby","volume":"10","author":"Lawn","year":"2013","journal-title":"Reprod Health"},{"key":"R2-20260504","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","article-title":"National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: A systematic analysis and implications","volume":"379","author":"Blencowe","year":"2012","journal-title":"Lancet"},{"key":"R3-20260504","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/s41433-019-0643-4","article-title":"Retinopathy of prematurity treatment: Asian perspectives","volume":"34","author":"Sen","year":"2020","journal-title":"Eye (Lond)"},{"key":"R4-20260504","doi-asserted-by":"crossref","first-page":"e20153218","DOI":"10.1542\/peds.2015-3218","article-title":"Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity","volume":"137","author":"Morin","year":"2016","journal-title":"Pediatrics"},{"key":"R5-20260504","doi-asserted-by":"crossref","first-page":"860","DOI":"10.4103\/ijo.IJO_325_19","article-title":"Safety and efficacy of 532 nm frequency-doubled Nd-YAG green laser photocoagulation for treatment of retinopathy of prematurity","volume":"67","author":"Singh","year":"2019","journal-title":"Indian J Ophthalmol"},{"key":"R6-20260504","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4103\/0301-4738.126179","article-title":"Recent developments in retinal lasers and delivery systems","volume":"62","author":"Yadav","year":"2014","journal-title":"Indian J Ophthalmol"},{"key":"R7-20260504","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/eye.2013.205","article-title":"Pain score assessment in babies undergoing laser treatment for retinopathy of prematurity under sub-tenon anaesthesia","volume":"27","author":"Novitskaya","year":"2013","journal-title":"Eye (Lond)"},{"key":"R8-20260504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.eye.6700295","article-title":"Retinopathy of prematurity in practice. II: Long-term results following treatment for threshold disease","volume":"17","author":"Gnanaraj","year":"2003","journal-title":"Eye (Lond)"},{"key":"R9-20260504","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0161-6420(02)01169-7","article-title":"Acquired cataracts after diode laser photocoagulation for threshold retinopathy of prematurity","volume":"109","author":"Paysse","year":"2002","journal-title":"Ophthalmology"},{"key":"R10-20260504","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/bjo.2009.168583","article-title":"Frequency-doubled Nd:YAG (532 nm green) versus diode laser (810 nm) in treatment of retinopathy of prematurity","volume":"94","author":"Sanghi","year":"2010","journal-title":"Br J Ophthalmol"},{"key":"R11-20260504","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0002-9394(14)73870-X","article-title":"Cataract in infants treated with argon laser photocoagulation for threshold retinopathy of prematurity","volume":"119","author":"Christiansen","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"R12-20260504","doi-asserted-by":"crossref","first-page":"277","DOI":"10.18240\/ijo.2021.02.15","article-title":"Effects of diode laser photocoagulation treatment on ocular biometric parameters in premature infants with retinopathy of prematurity","volume":"14","author":"Acar","year":"2021","journal-title":"Int J Ophthalmol"},{"key":"R13-20260504","doi-asserted-by":"crossref","first-page":"835","DOI":"10.4103\/ijo.IJO_872_16","article-title":"Refractive and ocular biometric profile of children with a history of laser treatment for retinopathy of prematurity","volume":"65","author":"Kaur","year":"2017","journal-title":"Indian J Ophthalmol"},{"key":"R14-20260504","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jaapos.2021.09.004","article-title":"Prevalence of persistent avascular retina in untreated children with a history of retinopathy of prematurity screening","volume":"26","author":"Hanif","year":"2022","journal-title":"J AAPOS"},{"key":"R15-20260504","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/IAE.0b013e3181a68f3a","article-title":"Aggressive posterior retinopathy of prematurity in Asian Indian babies: Spectrum of disease and outcome after laser treatment","volume":"29","author":"Sanghi","year":"2009","journal-title":"Retina"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2490_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:40:13Z","timestamp":1786650013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_2490_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,5]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_2490_23","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,5]]},"assertion":[{"value":"2023-09-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-11-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}